OBJECTIVE -To evaluate health care access and utilization and health status and outcomes for type 2 diabetic patients according to race and ethnicity and to determine whether health status is influenced by health care access and utilization.
I
n the U.S., there is considerable variation by race and ethnicity in health care access and utilization for a number of diseases and conditions. For example, surgery rates were substantially lower for African-American patients with resectable nonsmall-cell lung cancer than for Caucasian patients, which accounted for the lower survival rate of the AfricanAmerican patients (1) . African-American and Hispanic women were less likely to have mammograms and more likely to present with late-stage breast cancer than Caucasian women (2, 3) . The use of antiretroviral therapy was significantly less common for African-Americans and Latinos in a national sample of people with AIDS (4) . African Americans were less likely to have cardiac procedures, including reperfusion therapy for myocardial infarction, cardiac catheterization, coronary artery bypass graft surgery, and percutaneous transluminal coronary angioplasty (5, 6) .
For diabetic patients, such variation in health care access and utilization has not been documented. Nevertheless, considerable attention has been garnered by the concept that access and utilization are major determinants of quality of care and health outcomes in diabetes. It is widely believed that diabetes care in the U.S. is suboptimal and that patients with diabetes are not receiving the care known to be beneficial. For example, the Diabetes Quality Improvement Project (DQIP), sponsored by a number of organizations with interest in diabetes, was created to assess the level of care provided to patients with diabetes and to improve the accountability of the health system (7) .
It is well established that racial and ethnic differences exist in end-stage clinical outcomes for diabetic patients. Microvascular complications of the eyes, nerves, and kidneys and lower extremity amputations are more common in African-Americans, Hispanic Americans, and Native Americans with diabetes than in non-Hispanic Caucasian patients (8 -15) . However, these end-stage complications result only after a long duration of diabe-tes and thus occur in patients who were diagnosed and received much of their medical care many years ago. The current contribution of the health care system to these racial and ethnic differences in adverse health outcomes versus the contributions of patient self-care practices and inherent biological and genetic factors is yet undetermined.
To investigate these issues, we analyzed data from the third National Health and Nutrition Examination Survey (NHANES III), in which questionnaire, clinical, and laboratory data on health care access, utilization, and medical outcomes were obtained for a representative sample of type 2 diabetic adults. The outcomes studied were those that are expected to be influenced by recent medical care, such as hyperglycemia, albuminuria, hypertension, and dyslipidemia.
RESEARCH DESIGN AND METHODS -NHANES III was conducted from 1988 to 1994 and included a stratified probability sample of the civilian noninstitutionalized U.S. population, with oversampling of African-Americans and Mexican-Americans. The design and conduct of the survey has been described (16) . Participants were interviewed in their homes and were given a standardized set of examinations and laboratory measurements in an examination center. There were 16,993 participants Ն25 years of age, 1,608 of whom reported that they had been diagnosed with diabetes by a physician before the survey. Women with diabetes diagnosed only during pregnancy (n ϭ 105) and subjects with type 1 diabetes, defined as those Ͻ30 years of age at diagnosis who had continuous insulin use since diagnosis of diabetes (n ϭ 23), were eliminated from analysis. The remaining 1,480 subjects were considered to have type 2 diabetes and included 590 non-Hispanic Caucasians, 405 non-Hispanic African-Americans, 450 Mexican-Americans, and 35 individuals of other races and ethnicities.
Information on sociodemographic and lifestyle characteristics, diabetes treatment, medical history, and health care utilization was obtained by structured questionnaires. Measurements of height, weight, HbA 1c , urine albumin and creatinine, blood pressure, and lipids were made during a separate clinical examination in which 88.2% of the interviewed subjects participated (n ϭ 1,306) (17) . Those who were examined did not differ from those who were not examined (16) . Measures of functional status and quality of life were not obtained in NHANES III. Hypertension was defined as systolic blood pressure Ն140 mmHg or diastolic blood pressure Ն90 mmHg or taking antihypertensive medication. Dyslipidemia was defined as LDL cholesterol Ն130 mg/dl or treatment with prescribed diet or medication. Definitions of treatment goals and abnormal values for HbA 1c , proteinuria, obesity, blood pressure, and blood lipids are those recommended by professional scientific organizations (18 -21) .
Statistical analyses were carried out using SAS (Cary, NC) with appropriate sampling weights to adjust for the stratified sample design. Standard errors were calculated and tests of statistical significance and logistic regression were performed using SUDAAN (Research Triangle Institute, Research Triangle Park, NC). Logistic regression with usual source of health care, number of physician visits, and any or private health insurance as independent variables was conducted for each race and ethnic group to examine whether there was any influence of these health care variables on health status and outcomes. Education and income were included as independent variables in additional models to determine whether there was any influence of socioeconomic status.
RESULTS -Of all patients, 74.4% were non-Hispanic Caucasian, 15.0% were non-Hispanic African-American, 5.8% were Mexican-American, and 4.8% were of other race and ethnicity. Table 1 compares characteristics of the three main race and ethnic groups. Non-Hispanic Caucasians were older and greater proportions of them were male, had completed high school, and had family income Ն$20,000. Caucasian men were heavier than African-American and MexicanAmerican men, and African-American women were heavier than Caucasian and Mexican-American women. NonHispanic African-Americans had a longer duration since diagnosis of diabetes and a greater proportion had hypertension. Mexican-Americans had the lowest rates of hypertension and dyslipidemia.
Health care access and utilization Health care access and utilization are shown in Table 2 . Almost all patients in each race and ethnic group had one primary source of ambulatory medical care, described as a physician's office, clinic, or health center. Most of these patients consistently saw one specific physician at this source; 83-90% had at least semi-annual visits, and 62-68% had at least quarterly visits. Almost all patients Ն65 years of age had health insurance of some type (private insurance, Medicare, Medicaid, Champus, or Veterans Administration). However, for those patients Ͻ65 years of age, Caucasians and African-Americans had higher rates of coverage than Mexican-Americans.
A larger proportion of AfricanAmericans was treated with insulin, but a smaller proportion was treated using oral agents, such that the rates of pharmacological treatment were similar for each race and ethnic group (Table 2) . Approximately half of the patients treated with insulin took two or more injections per day; the rates in African-Americans and Mexican-Americans were lower than those for Caucasians. Self-monitoring of blood glucose was rare among patients who were not treated with insulin. Among insulin-treated patients, a lower proportion of African-Americans and Mexican-Americans self-monitored their blood glucose than Caucasians. About two-thirds of patients had a dilated eye examination during the previous year, and almost all patients had their blood pressure checked within the previous 6 months. Differences by race and ethnicity in these procedures were not statistically significant.
Clinical hypertension was present in 66% of Caucasian patients, 71% of African-Americans, and 54% of MexicanAmericans (Table 1) . Of those with hypertension, most were being treated with antihypertensive medication ( Table  2 ). The proportion of hypertension that was untreated or undiagnosed was higher in Mexican-Americans (29%) than in Caucasians (17%) or African-Americans (16%). Dyslipidemia was present in 65% of Caucasians, 62% of African-Americans, and 51% of Mexican-Americans (Table 1) . Much of the dyslipidemia was untreated by either diet or medication or was undiagnosed in all three race and ethnic groups (Table 2) .
Health status and outcomes
Health status and outcome measures that were expected to be influenced by recent medical care are shown in Table 3 . Although some measures were more severe in African-Americans and MexicanAmericans, these differences were often small or not statistically significant. African-Americans and Mexican-Americans had somewhat higher proportions of HbA 1c Ն7%, clinical proteinuria, and blood pressure Ն140/90 mmHg among those with diagnosed hypertension. In contrast, they had better levels of total cholesterol and HDL cholesterol than Caucasians, and African-American and Mexican-American men were less overweight than Caucasian men (although the opposite was true for women).
More than half of each group had an HbA 1c value Ͼ7.0%, the recommended treatment goal for blood glucose control, and one-third of each group had either microalbuminuria or clinical proteinuria (Table 3) . Of those whose hypertension had been diagnosed before the survey, more than half of each race and ethnic group were not controlled to the level of Ͻ140/90 mmHg, even though 70 -80% of these individuals were taking antihypertensive medication. An aggressive approach, including dietary changes and Data are %. Sample sizes for hypertension (n ϭ 864) and dyslipidemia (n ϭ 627) exclude subjects who do not have these conditions; dyslipidemia data also exclude subjects with triglyceride levels Ն400 mg/dl for whom the Friedewald equation to compute LDL cholesterol is not valid. *P Ͻ 0.001, †P Ͻ 0.01, and ‡P Ͻ 0.05 compared with non-Hispanic Caucasians.
drug therapy, is recommended for diabetic patients who have LDL cholesterol values Ն130 mg/dl. In NHANES III, of those who had previously been diagnosed with dyslipidemia, only approximately one-third had LDL cholesterol Ͻ130 mg/dl, although most were being treated with diet and/or medication. The percentage distributions for total cholesterol, HDL cholesterol, triglycerides, and LDL cholesterol are shown in Table 3 . Large proportions of each race and ethnic group had levels that were above normal for each lipid variable. Elevated levels of lipoprotein(a) were found more often in African-Americans than in Caucasians and Mexican-Americans. Rates of homocysteinuria, cigarette smoking, and hospitalization in the previous year were similar among the three groups. 
2). Hypertensive
African-Americans with six or more physician visits in the previous year were more likely to have blood pressure Ͻ140/90 mmHg than those with less than six visits (OR 1.5, CI 1.2-4.8). The 93% of African-Americans with any type of health insurance were more likely than the 7% without insurance to have HbA 1c Ͻ7.0% (OR 3.7, CI 1.1-12.5) and to have albumin-to-creatinine ratio Ͻ30 mg/g (2.7, 1.1-6.5). African-Americans and Mexican-Americans with private health insurance (56 and 45% of these groups, respectively) were more likely to have albumin-to-creatinine ratio Ͻ30 mg/g (OR 1.6, CI 1.1-2.4 and OR 2.1, CI 1.2-3.3, respectively).
Because of the many logistic regressions performed and the wide CIs, the clinical and statistical significance of these few exceptions should be considered with reservation. There was no association of socioeconomic status, measured by levels of education and income, with blood glucose control, hypertension control, lipid control, or albuminuria in Caucasians, African-Americans, or Mexican-Americans, with only one exception: MexicanAmericans with a high school education or more were twice as likely to have normoalbuminuria as those with less than a high school education (OR 2.1, CI 1.1-4.1).
CONCLUSIONS -These data indicate that there are some differences among Caucasians, African-Americans, and Mexican-Americans in health care access and utilization and in health status and outcome measures that are influenced by recent medical care, such as hy- Data are %. The upper limit of normal for HbA 1c in the assay system is 6.1%, defined as the mean ϩ 2 SD (5.27 ϩ 0.85%) for the group of people with fasting plasma glucose Ͻ110 mg/dl and 2-h postchallenge glucose Ͻ140 mg/dl. Samples sizes for previously diagnosed hypertension (n ϭ 618) and previously diagnosed dyslipidemia (n ϭ 302) exclude subjects who have not been diagnosed with these conditions; dyslipidemia data also exclude subjects with triglyceride levels Ն400 mg/dl for whom the Friedewald equation to compute LDL cholesterol is not valid. *P Ͻ 0.01, †P Ͻ 0.001, and ‡P Ͻ 0.05 compared with non-Hispanic Caucasians.
perglycemia, albuminuria, hypertension, and dyslipidemia. However, many of the differences are small or are not statistically significant. More importantly, the magnitude of the differences pale in comparison with the suboptimal health status of all three race and ethnic groups relative to current treatment goals for blood glucose, blood pressure, lipids, and albuminuria.
In each race and ethnic group, there were high rates of health care access and utilization, screening for diabetes complications, and treatment of hyperglycemia, hypertension, and dyslipidemia. Nevertheless, in each group, glycemic control was poor; many patients were obese and had albuminuria, and much of the hypertension and dyslipidemia was not controlled. One-fourth of patients had to be hospitalized in the previous year, and one-fifth of patients smoked cigarettes. In logistic regression, there was little evidence in any of the race and ethnic groups that health status and outcomes were influenced by access to or utilization of health care or by socioeconomic status.
As previously discussed (17) , it is likely that health outcomes for patients with diabetes are determined by multiple factors, including intractability of diabetes to current therapies, patient self-care practices, physician medical care practices, and characteristics of U.S. health care systems, rather than by the race and ethnicity of diabetic patients.
Only a few previous studies have examined race and ethnic differences in health care for diabetes. For Medicare patients in 1993, rates for quality of care measures were low for all patients. There were small differences between AfricanAmericans and Caucasians in health perception, but not in rates of diabetes complications or ability to perform activities of daily living. African-Americans less frequently had data recorded in their insurance claims showing that HbA 1c was measured, an ophthalmic visit was made, lipids were measured, and influenza vaccination was administered, but rates were not different for mammograms or hospitalization follow-up (22) . In another study of Medicare records in 1992, race was not a predictor of expenditures for diabetes care (23) . In a Michigan health maintenance organization (HMO) in 1991, African-Americans had higher HbA 1c and creatinine values, but both African-American and Caucasian patients infrequently received the medical care recommended by the American Diabetes Association (ADA) (24) . In a California HMO in 1992, an eight-point prevention score reflecting ADA guidelines for care and rates of diabetes complications did not differ by race (25) .
The literature is replete with studies showing that marked benefits to diabetic patients can accrue from reducing risk factors for diabetes complications. Improved glycemic control is associated with long-term health benefits such as decreased incidence of retinopathy, neuropathy, nephropathy, and other end-stage complications (26, 27) . It is also associated with substantial short-term improvements in quality of life, symptom distress, physical functioning, and economic benefits, including higher retained employment and less absenteeism (28) . In contrast, medical care charges increase significantly for increases in HbA 1c levels Ͼ7%, suggesting that investment in clinical systems to improve diabetes care may benefit both payers and patients (29) . The benefits of decreasing blood pressure and lipids are well recognized and include reductions in the risk of micro-and macrovascular disease and death (30 -32) . Socioeconomic status does not appear to be an important determinant of diabetes complications. Among Hispanics and Anglos in San Antonio, Texas, complications of diabetes were not related to socioeconomic status (33) . No association of glycemic control with income or education was found in Caucasians, African-Americans, or Mexican-Americans in NHANES III (34) .
